BEST ABSTRACT: A phase II trial of erlotinib (E) and bevacizumab (B) in patients with advanced non-small-cell lung cancer (NSCLC) with activating ep...

Date 28 September 2015
Event European Cancer Congress 2015
Session Presidential Session III
Topics Non-small-cell lung cancer
Presenter Stahel, R.A.